{"status":"ok","message-type":"event-list","message":{"next-cursor":"e6751b6d-cf7b-4ccf-9892-4ece8ae6f8e2","total-results":2,"items-per-page":1000,"events":[{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1136\/bmj.322.7281.261","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-01-30T00:00:00Z","subj_id":"https:\/\/lens.org\/002-337-157-215-170","id":"0fb8b837-0e47-ca84-fd68-6d2789a81655","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Pharmaceutical Composition Comprising Diamorphine For Intranasal Administration","pid":"https:\/\/lens.org\/002-337-157-215-170","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T04:02:15Z","relation_type_id":"cites"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1136\/bmj.322.7281.261","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2012-12-12T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1007\/s40140-012-0001-6","id":"e6751b6d-cf7b-4ccf-9892-4ece8ae6f8e2","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-12-10T01:35:57Z","relation_type_id":"references"}]}}